Comparison of99mTc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Comparison of99mTc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy

Published:2019-10 Issue:4 Volume:213 Page:932-943
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Hunt Katie N.¹,Conners Amy Lynn¹,Goetz Matthew P.²,O'Connor Michael K.¹,Suman Vera³,Kalari Krishna³,Weinshilboum Richard⁴,Wang Liewei⁴,Carter Jodi⁵,McLaughlin Sarah⁶,Aspitia Alvaro Moreno⁷,Gray Richard⁸,Northfelt Don⁹,Boughey Judy C.¹⁰

Affiliation:

1. Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

2. Department of Medical Oncology, Mayo Clinic, Rochester, MN.

3. Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.

4. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN.

5. Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN.

6. Department of Surgery, Mayo Clinic, Jacksonville, FL.

7. Department of Internal Medicine, Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.

8. Department of Surgery, Mayo Clinic, Scottsdale, AZ.

9. Department of Internal Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ.

10. Department of Surgery, Mayo Clinic, Rochester, MN.

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.18.20628

Reference34 articles.

1. Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer

2. Accuracy of Clinical Examination, Digital Mammogram, Ultrasound, and MRI in Determining Postneoadjuvant Pathologic Tumor Response in Operable Breast Cancer Patients

3. Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR Appropriateness Criteria® Imaging of Invasive Breast Cancer;Journal of the American College of Radiology;2024-06

2. Molecular Breast Imaging and Positron Emission Mammography;PET Clinics;2023-10

3. Evaluation of Treatment Response in Patients with Breast Cancer;PET Clinics;2023-10

4. ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update;Journal of the American College of Radiology;2023-05

5. Multimodality Imaging Review of HER2-positive Breast Cancer and Response to Neoadjuvant Chemotherapy;RadioGraphics;2023-02-01